Back
Xeris Biopharma Holdings Stock Price Chart
Sponsored
XERS
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
86
XERS
Xeris Biopharma Holdings
Last Price:
3.44
Seasonality Move:
5.57%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Xeris Biopharma Holdings Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.04 | Buy |
20-day SMA: | 3.16 | Buy |
50-day SMA: | 3.04 | Buy |
200-day SMA: | 2.51 | Buy |
8-day EMA: | 3.09 | Buy |
20-day EMA: | 3.11 | Buy |
50-day EMA: | 3.02 | Buy |
200-day EMA: | 2.61 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 55.23 | Buy |
Chaikin Money Flow: | 912319 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.04 - 3.3) | Buy |
Bollinger Bands (100): | (2.49 - 3.11) | Buy |
Xeris Biopharma Holdings Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.18 while XERS 8-day simple moving average is 3.04, which is a Buy signal.
- The stock price of XERS is 3.18 while Xeris Biopharma Holdings 20-day SMA is 3.16, which makes it a Buy.
- Xeris Biopharma Holdings 50-day simple moving average is 3.04 while XERS share price is 3.18, making it a Buy technically.
- XERS stock price is 3.18 and Xeris Biopharma Holdings 200-day simple moving average is 2.51, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
86
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a Buy
The current Xeris Biopharma Holdings [XERS] share price is $3.18. The Score for XERS is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
474.08M
Price in USD:
3.18
Share Volume:
1.32M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.64
52-Week Low:
1.69
Buy
86
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?
The Xeris Biopharma Holdings stock price is 3.18 USD today. -
Will XERS stock go up or go down?
Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Xeris Biopharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.18 while XERS 8-day exponential moving average is 3.09, which is a Buy signal.
- The stock price of XERS is 3.18 while Xeris Biopharma Holdings 20-day EMA is 3.11, which makes it a Buy.
- Xeris Biopharma Holdings 50-day exponential moving average is 3.02 while XERS share price is 3.18, making it a Buy technically.
- XERS stock price is 3.18 and Xeris Biopharma Holdings 200-day simple moving average is 2.61, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
- XERS Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Xeris Biopharma Holdings is a Buy
- Xeris Biopharma Holdings Relative Strength Index (RSI) is 55.23, which suggest Xeris Biopharma Holdings is overbought
- The Bollinger Bands (25) for Xeris Biopharma Holdings is (3.04 - 3.3), which suggest Xeris Biopharma Holdings is a Buy
- The Bollinger Bands (100) for Xeris Biopharma Holdings is (2.49 - 3.11), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.